+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Olaparib"

CAS 763113-22-0 (937799-91-2) Olaparib Chemical World Report - Product Thumbnail Image

CAS 763113-22-0 (937799-91-2) Olaparib Chemical World Report

  • Report
  • September 2020
  • 2189 Pages
Global and Chinese Olaparib Market Insights 2019: Analysis and Forecast to 2024 - By Manufacturers, Product Type, Application, Regions and Technology - Product Thumbnail Image

Global and Chinese Olaparib Market Insights 2019: Analysis and Forecast to 2024 - By Manufacturers, Product Type, Application, Regions and Technology

  • Report
  • June 2019
  • 145 Pages
From
Castrate-resistant Prostate Cancer (CRPC) -Market Insights, Epidemiology and Market Forecast - 2030 - Product Thumbnail Image

Castrate-resistant Prostate Cancer (CRPC) -Market Insights, Epidemiology and Market Forecast - 2030

  • Drug Pipelines
  • June 2020
  • 200 Pages
From
Prostate Cancer - Market Insights, Epidemiology and Market Forecast - 2030 - Product Thumbnail Image

Prostate Cancer - Market Insights, Epidemiology and Market Forecast - 2030

  • Drug Pipelines
  • June 2020
  • 250 Pages
From
Hormone Receptor (HR) Positive/ Human Epidermal Receptor 2 (HER2) Negative Breast Cancer - Market Insights, Epidemiology and Market Forecast - 2030 - Product Thumbnail Image

Hormone Receptor (HR) Positive/ Human Epidermal Receptor 2 (HER2) Negative Breast Cancer - Market Insights, Epidemiology and Market Forecast - 2030

  • Drug Pipelines
  • May 2020
  • 200 Pages
From
Global Ovarian Cancer Drugs Market 2019-2025 - Product Thumbnail Image

Global Ovarian Cancer Drugs Market 2019-2025

  • Report
  • January 2020
From
Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence - Product Thumbnail Image

Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence

  • Report
  • May 2018
  • 215 Pages
From
Global Fallopian Tube Cancer Market - Segmented by Therapy Type, and Geography - Growth, Trends, and Forecast (2018 - 2023) - Product Thumbnail Image

Global Fallopian Tube Cancer Market - Segmented by Therapy Type, and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • Report
  • April 2018
  • 112 Pages
From
North America Ovarian Cancer Diagnostics and Therapeutics Market - Segmented by Cancer Type, Cancer Stage, Diagnosis, Treatment, and Geography - Growth, Trends, and Forecast (2018 - 2023) - Product Thumbnail Image

North America Ovarian Cancer Diagnostics and Therapeutics Market - Segmented by Cancer Type, Cancer Stage, Diagnosis, Treatment, and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • Report
  • March 2018
  • 90 Pages
From
Middle East & Africa Ovarian Cancer Diagnostics and Therapeutics Market - Segmented by Cancer Type, Cancer Stage, Diagnosis, Treatment, and Geography - Growth, Trends, and Forecast (2018 - 2023) - Product Thumbnail Image

Middle East & Africa Ovarian Cancer Diagnostics and Therapeutics Market - Segmented by Cancer Type, Cancer Stage, Diagnosis, Treatment, and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • Report
  • March 2018
  • 90 Pages
From
Asia-Pacific Ovarian Cancer Diagnostics and Therapeutics Market - Segmented by Cancer Type, Cancer Stage, Diagnosis, Treatment, and Geography - Growth, Trends, and Forecast (2018 - 2023) - Product Thumbnail Image

Asia-Pacific Ovarian Cancer Diagnostics and Therapeutics Market - Segmented by Cancer Type, Cancer Stage, Diagnosis, Treatment, and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • Report
  • March 2018
  • 90 Pages
From
Drug Overview: Lynparza - Product Thumbnail Image

Drug Overview: Lynparza

  • Drug Pipelines
  • January 2018
  • 61 Pages
From
PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2026 - Product Thumbnail Image

PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2026

  • Report
  • November 2017
  • 413 Pages
From
Prostate Cancer - Newer Antiandrogens & Emerging Therapies Targeting a “Watchful Waiting” and Resistance Population - Product Thumbnail Image

Prostate Cancer - Newer Antiandrogens & Emerging Therapies Targeting a “Watchful Waiting” and Resistance Population

  • Report
  • January 2017
  • 200 Pages
From
Breast Cancer: Triple - Negative: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis - Product Thumbnail Image

Breast Cancer: Triple - Negative: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

  • Drug Pipelines
  • May 2016
  • 290 Pages
From
Breast Cancer: Hr+/Her2-: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis - Product Thumbnail Image

Breast Cancer: Hr+/Her2-: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

  • Drug Pipelines
  • April 2016
  • 273 Pages
From
Ovarian Cancer: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis - Product Thumbnail Image

Ovarian Cancer: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

  • Drug Pipelines
  • March 2016
  • 239 Pages
From
Breast Cancer: New targeted therapies transform treatment - KOL Insight - Product Thumbnail Image

Breast Cancer: New targeted therapies transform treatment - KOL Insight

  • Report
  • February 2014
  • 153 Pages
From
  • 18 Results (Page 1 of 1)
Loading Indicator
adroll